14-Jun-2012 By Nick Taylor
Biogen Idec expects the market for injectable MS drugs to shrink as patients choose more convenient delivery forms.
13-Jun-2012 By Nick Taylor
Eli Lilly will use its drug delivery device capabilities to boost the competitiveness of its developmental basal insulins, the firm’s SVP said.
13-Jun-2012 By Nick Taylor
Bayer is trying to protect its manufacturing process for a chewable drug delivery dosage form with a US patent application.
12-Jun-2012 By Natalie Morrison
The CEO of Lycotec says its chocolate formulation of a liver-targeted oral compound has attracted interest from the NIH and FDA.
07-Jun-2012 By Nick Taylor
in-PharmaTechnologist.com presents a roundup of drug delivery news, including a FDA set back at Amylin and expansion at Particle Sciences.
04-Jun-2012 By Nick Taylor
AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.
28-May-2012 By Nick Taylor
West Pharmaceutical Services expects significant growth from biosimilars as manufacturers use novel delivery devices as a “key differentiator”.
UPDATE
22-May-2012 By Natalie Morrison
Prosonix says its new ‘smart’ excipient-free drug particles can improve the delivery of inhaled combination therapies.
22-May-2012 By Gareth Macdonald
Ideal Cures has expanded its drug delivery tech portfolio with a new alginic acid-based, delayed-release coating that – it claims – has advantages over shellac and starch.
09-May-2012 By Natalie Morrison
Aptar Pharma has launched a new twistable dry powder inhaler (DPI) which it says is a “cost effective” way to improve drug delivery as well as patient compliance.
07-May-2012 By Nick Taylor
The need for novel delivery technologies is greater than ever as firms scramble to extract maximum value from drugs, an Interphex speaker said.
30-Apr-2012 By Nick Taylor
West has raised its outlook for 2012 after a shift in supply chain attitude by clients drove strong first quarter sales.
25-Apr-2012 By Natalie Morrison
Tamarisk Technologies is in licensing talks with several Big Pharmas over a tech which it claims could solve the oral insulin puzzle and “turn the industry upside down”.
17-Apr-2012 By Nick TAYLOR
Novo Nordisk has told the FDA allowing alternative delivery devices for biosimilars creates “significant safety implications”.
12-Apr-2012 By Nick Taylor
Demand for insulin pens and ready-to-fill syringes helped Gerresheimer post double-digit first quarter sales growth and raise its outlook.
21-Mar-2012 By Nick Taylor
Teva will try to use different delivery devices for biosimilars to gain an edge over innovator products, its North American CEO said.
20-Mar-2012 By Nick Taylor
The US FDA will today publish a final rule to change cGMP labelling controls, 15 years after proposing the revision.
EXCLUSIVE
28-Feb-2012 By Natalie Morrison
Reduced-pain injection systems are the key to gaining regulatory approval for new products, according to BD.
Glenmark recalling birth control pills after packaging error
27-Feb-2012
Glenmark is recalling incorrectly packaged birth control pills from the US, less than one month after Pfizer took similar actions.
21-Feb-2012 By Natalie Morrison
Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials.
Pfizer and Mylan settle drug delivery patent case with Sanofi
21-Feb-2012
Pfizer and Mylan have settled patent litigation with Sanofi over a pre-filled drug delivery device used to treat allergic reactions.
20-Feb-2012 By Nick Taylor
West Pharmaceutical Services posted another flat quarter of proprietary delivery product sales but is predicting “notable increases” in 2012.
13-Feb-2012 By Nick Taylor
The FDA has said biosimilars can use different drug delivery devices than their reference products in its long-awaited guidance.
09-Feb-2012 By Nick Taylor
BD posted double-digit revenue growth in China as government spending on healthcare continued despite economic pressures.
01-Feb-2012 By Nick Taylor
Pfizer is recalling 28 lots of contraceptives after a blister packaging error raised the risk of unintended pregnancy.
Cephalon begins recall after glass flakes found in vial
31-Jan-2012
Cephalon is recalling a single lot of leukaemia treatment Treanda after glass fragments were found in a vial.
30-Jan-2012 By Nick Taylor
Zogenix is collaborating with Battelle to out-license its needle-free drug delivery technology, DosePro.
02-Jan-2012 By Natalie Morrison
BASF’s new multi-functional plastic film will raise the bar for purity levels in synthetic excipients, says the firm.
22-Dec-2011 By Natalie Morrison
Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.
Stevanato expands its ready-to-fill glass vial capabilities
UPDATE
06-Dec-2011 By Natalie Morrison
Stevanato Group has pulled forward the expansion of its EZ-Fill facility in Italy by one year in a bid to dominate a bigger portion of the “rapidly expanding” ready-to-fill vials market.
USPTO rejects MonoSol claims in delivery film patent fight with BDSI
29-Nov-2011 By Gareth Macdonald
The USPTO has rejected MonoSol RX’s claims that production methods for a cancer pain patch developed by BioDelivery Sciences (BDSI) infringe on manufacturing techniques it uses to make its own drug delivery films.
EC seeks industry feedback to shape serialisation policy
24-Nov-2011 By Nick Taylor
The EC is seeking industry comments before implementing the serialisation aspect of the falsified medicines directive.
Schott strikes deal with Xinkang for joint venture in China
22-Nov-2011 By Alexandria Pesic
German technology giant Schott has signed an agreement with a Chinese firm to provide the fast-growing pharmaceutical market with a range of high-end glass packaging products.
Biocon introduces insulin pen to Indian market
22-Nov-2011
Biocon has begun selling a reusable insulin pen, based on Haselmeier technology, to patients in India.
IntraPac hiring 63 in NJ to IN packaging plant relocation
21-Nov-2011
IntraPac is creating 63 jobs by relocating operations from New Jersey to an 80,000 sq ft packaging plant in Indiana.
Trust in drug source may blind wholesalers to counterfeits
15-Nov-2011 By Nick Taylor
Wholesalers’ trust in the quality of products from some countries could decrease vigilance and allow counterfeits to reach pharmacies, research found.
Neuroderm hopeful for its Phase II Parkinson's medication patch
10-Nov-2011 By Natalie Morrison
Neuroderm has seen “promising” results in its Phase II clinical trial of a new drug delivery patch to increase the efficacy of Parkinson’s medication.
Bosch packaging to open second production plant in China
09-Nov-2011 By Natalie Morrison
Bosch Packaging has started work on a second production facility in Chengdu, China to increase manufacturing capacity.
31-Oct-2011 By Natalie Morrison
Medimetrics is collaborating with Bio-Images to offer its electronic targeted drug delivery tech to clinical researchers.
27-Oct-2011 By Natalie Morrison
A new antiretroviral (ARV) transdermal delivery patch developed at ImQuest Biosciences will wipe out the need for the “cocktail” of oral medication HIV sufferers have to take every day.
19-Oct-2011 By Nick Taylor
Gathering data with RFID can ensure reliable pharma packaging supply by improving delivery date predictions, researchers claim.
Honeywell adds high barrier film for hot & humid climates
18-Oct-2011 By Nick Taylor
Honeywell has introduced a high moisture barrier film to protect sensitive pharmaceuticals in hot and humid climates.
13-Oct-2011 By Nick Taylor
Sproxil and Orange have separately expanded text messaging anti-counterfeiting services in Kenya to tackle fake drugs.
EU Commission may revise guidance on pharma literature
13-Oct-2011 By Natalie Morrison
The EU Commission could soon revise its guidance for information allowed on packaging of prescription-only medicines, after European Parliament urged it to update its original policy.
Melanoma therapy costs could be slashed thanks to new device, says OncoSec
06-Oct-2011 By Natalie Morrison
The price of melanoma therapy could soon be slashed thanks to a new delivery system developed by US firm OncoSec.
Insulin pens & Brazil buy drive Gerresheimer growth
06-Oct-2011 By Nick Taylor
Gerresheimer posted a jump in sales and upgraded guidance on strong demand for insulin pens and the Vedat acquisition.
Bespak's nasal delivery device wins firm second development deal
04-Oct-2011 By By Natalie Morrison
Bespak has won its second nasal delivery device development deal in as many months for a major global manufacturer of generic medicines.
Intercell hopeful for future of needle-free vaccine
29-Sep-2011 By Natalie Morrison
Intercell is seeking new partnerships for its struggling needle-free patch system for delivering vaccines.
Drug delivery round-up
20-Sep-2011 By Natalie Morrison
in-PharmaTechnologist presents its round-up of the latest in the world of drug delivery, including news from Sanofi Pasteur, Haselmeier, Unigene, and Southwest Research Institute.
Circassia and NanoPass strike up deal over intradermal device
19-Sep-2011 By Natalie Morrison
Immunotherapy and vaccine specialist Circassia says its new license agreement with NanoPass Technologies will help its range of allergy products to thrive on the market.
